{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:22:21Z","timestamp":1788326541342,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":75,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-026-06012-w","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T18:04:24Z","timestamp":1781892264000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular surveillance of antimalarial drug resistance markers in the pfcrt, pfmdr1 and pfmrp1 genes of Plasmodium falciparum isolates from southeastern Iran"],"prefix":"10.1186","volume":"25","author":[{"given":"Mohadeseh","family":"Jafari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Rezapour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahimeh","family":"Nemati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram Abouie","family":"Mehrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakineh","family":"Pirahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"6012_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss7002a1","volume":"70","author":"KE Mace","year":"2021","unstructured":"Mace KE, Lucchi NW, Tan KR. Malaria surveillance \u2013 United States, 2017. MMWR Surveill Summ. 2021;70:1\u201335.","journal-title":"MMWR Surveill Summ"},{"key":"6012_CR2","volume-title":"World malaria report 2025","author":"WHO","year":"2025","unstructured":"WHO. World malaria report 2025. Geneva: World Health Organization; 2025."},{"key":"6012_CR3","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.3390\/ijms26135977","volume":"26","author":"R de Abreu-Fernandes","year":"2025","unstructured":"de Abreu-Fernandes R, de Queiroz LT, Almeida-de-Oliveira NK, de Lavigne Mello AR, de Barros JA, Pratt-Riccio LR, et al. Tracking drug resistance in Plasmodium falciparum: genetic diversity of key resistance markers in Brazilian malaria hotspots. Int J Mol Sci. 2025;26:5977.","journal-title":"Int J Mol Sci"},{"key":"6012_CR4","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jiph.2022.03.015","volume":"15","author":"BJ Njiro","year":"2022","unstructured":"Njiro BJ, Mutagonda RF, Chamani AT, Mwakyandile T, Sabas D, Bwire GM. Molecular surveillance of chloroquine-resistant Plasmodium falciparum in sub-Saharan African countries after withdrawal of chloroquine for treatment of uncomplicated malaria: a systematic review. J Infect Public Health. 2022;15:550\u20137.","journal-title":"J Infect Public Health"},{"key":"6012_CR5","volume-title":"Guidelines for the treatment of malaria","author":"WHO","year":"2015","unstructured":"WHO. Guidelines for the treatment of malaria. 3rd ed. Geneva: WHO; 2015.","edition":"3"},{"key":"6012_CR6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455\u201367.","journal-title":"N Engl J Med"},{"key":"6012_CR7","volume-title":"Status report on artemisinin and ACT resistance","author":"WHO","year":"2016","unstructured":"WHO. Status report on artemisinin and ACT resistance. Geneva: WHO; 2016."},{"key":"6012_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411\u201323.","journal-title":"N Engl J Med"},{"key":"6012_CR9","doi-asserted-by":"publisher","first-page":"a025619","DOI":"10.1101\/cshperspect.a025619","volume":"7","author":"D Menard","year":"2017","unstructured":"Menard D, Dondorp A. Antimalarial drug resistance: a threat to malaria elimination. Cold Spring Harb Perspect Med. 2017;7:a025619.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"6012_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1473-3099(18)30068-9","volume":"18","author":"R Amato","year":"2018","unstructured":"Amato R, Pearson RD, Almagro-Garcia J, Amaratunga C, Lim P, Suon S, et al. Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study. Lancet Infect Dis. 2018;18:337\u201345.","journal-title":"Lancet Infect Dis"},{"key":"6012_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1590\/S0074-02762012000100018","volume":"107","author":"G Awasthi","year":"2012","unstructured":"Awasthi G, Satya Prasad GB, Das A. Pfcrt haplotypes and the evolutionary history of chloroquine-resistant Plasmodium falciparum. Mem Inst Oswaldo Cruz. 2012;107:129\u201334.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"6012_CR12","doi-asserted-by":"publisher","first-page":"11672","DOI":"10.1073\/pnas.1507142112","volume":"112","author":"S Pelleau","year":"2015","unstructured":"Pelleau S, Moss EL, Dhingra SK, Volney B, Casteras J, Gabryszewski SJ, et al. Adaptive evolution of malaria parasites in French Guiana: reversal of chloroquine resistance by acquisition of a mutation in pfcrt. Proc Natl Acad Sci U S A. 2015;112:11672\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6012_CR13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1475-2875-13-244","volume":"13","author":"SK Mekonnen","year":"2014","unstructured":"Mekonnen SK, Aseffa A, Berhe N, Teklehaymanot T, Clouse RM, Gebru T, et al. Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia. Malar J. 2014;13:244.","journal-title":"Malar J"},{"key":"6012_CR14","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1007\/s00436-021-07323-4","volume":"120","author":"AM Madkhali","year":"2021","unstructured":"Madkhali AM, Abdulhaq AA, Atroosh WM, Ghzwani AH, Zain KA, Ghailan KY, et al. The return of chloroquine-sensitive Plasmodium falciparum parasites in Jazan region, southwestern Saudi Arabia over a decade after the adoption of artemisinin-based combination therapy: analysis of genetic mutations in the pfcrt gene. Parasitol Res. 2021;120:3771\u201381.","journal-title":"Parasitol Res"},{"key":"6012_CR15","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12936-015-0783-3","volume":"14","author":"L Golassa","year":"2015","unstructured":"Golassa L, Kamugisha E, Ishengoma DS, Baraka V, Shayo A, Baliraine FN, et al. Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania. Malar J. 2015;14:264.","journal-title":"Malar J"},{"key":"6012_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijpddr.2019.09.002","volume":"11","author":"E Hailemeskel","year":"2019","unstructured":"Hailemeskel E, Menberu T, Shumie G, Behaksra S, Chali W, Keffale M, et al. Prevalence of Plasmodium falciparum pfcrt and pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia. Int J Parasitol Drugs Drug Resist. 2019;11:8\u201312.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"6012_CR17","doi-asserted-by":"publisher","first-page":"668574","DOI":"10.3389\/fgene.2021.668574","volume":"12","author":"AT Roux","year":"2021","unstructured":"Roux AT, Maharaj L, Oyegoke O, Akoniyon OP, Adeleke MA, Maharaj R, et al. Chloroquine and sulfadoxine-pyrimethamine resistance in sub-Saharan Africa\u2014a review. Front Genet. 2021;12:668574.","journal-title":"Front Genet"},{"key":"6012_CR18","doi-asserted-by":"publisher","first-page":"7032","DOI":"10.1128\/AAC.03494-14","volume":"58","author":"N Wurtz","year":"2014","unstructured":"Wurtz N, Fall B, Pascual A, Fall M, Baret E, Camara C, et al. Role of pfmdr1 in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin. Antimicrob Agents Chemother. 2014;58:7032\u201340.","journal-title":"Antimicrob Agents Chemother"},{"key":"6012_CR19","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/35002615","volume":"403","author":"MB Reed","year":"2000","unstructured":"Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature. 2000;403:906\u20139.","journal-title":"Nature"},{"key":"6012_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1146\/annurev-micro-020518-115546","volume":"74","author":"KJ Wicht","year":"2020","unstructured":"Wicht KJ, Mok S, Fidock DA. Molecular mechanisms of drug resistance in Plasmodium falciparum malaria. Annu Rev Microbiol. 2020;74:431\u201354.","journal-title":"Annu Rev Microbiol"},{"key":"6012_CR21","doi-asserted-by":"publisher","first-page":"e000999","DOI":"10.1136\/bmjgh-2018-000999","volume":"3","author":"LC Okell","year":"2018","unstructured":"Okell LC, Reiter LM, Ebbe LS, Baraka V, Bisanzio D, Watson OJ, et al. Emerging implications of policies on malaria treatment: genetic changes in the pfmdr1 gene affecting susceptibility to artemether-lumefantrine and artesunate-amodiaquine in Africa. BMJ Glob Health. 2018;3:e000999.","journal-title":"BMJ Glob Health"},{"key":"6012_CR22","doi-asserted-by":"publisher","first-page":"833","DOI":"10.4269\/ajtmh.14-0031","volume":"91","author":"M Venkatesan","year":"2014","unstructured":"Venkatesan M, Gadalla NB, Stepniewska K, Dahal P, Nsanzabana C, Moriera C, et al. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Am J Trop Med Hyg. 2014;91:833\u201343.","journal-title":"Am J Trop Med Hyg"},{"key":"6012_CR23","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1086\/606009","volume":"200","author":"S Dahlstr\u00f6m","year":"2009","unstructured":"Dahlstr\u00f6m S, Ferreira PE, Veiga MI, Sedighi N, Wiklund L, M\u00e5rtensson A, et al. Plasmodium falciparum multidrug resistance protein 1 and artemisinin-based combination therapy in Africa. J Infect Dis. 2009;200:1456\u201364.","journal-title":"J Infect Dis"},{"key":"6012_CR24","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1046\/j.1365-2958.2003.03627.x","volume":"49","author":"J Mu","year":"2003","unstructured":"Mu J, Ferdig MT, Feng X, Joy DA, Duan J, Furuya T, et al. Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol Microbiol. 2003;49:977\u201389.","journal-title":"Mol Microbiol"},{"key":"6012_CR25","doi-asserted-by":"publisher","first-page":"e20212","DOI":"10.1371\/journal.pone.0020212","volume":"6","author":"MI Veiga","year":"2011","unstructured":"Veiga MI, Ferreira PE, J\u00f6rnhagen L, Malmberg M, Kone A, Schmidt BA, et al. Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance. PLoS ONE. 2011;6:e20212.","journal-title":"PLoS ONE"},{"key":"6012_CR26","doi-asserted-by":"publisher","first-page":"759422","DOI":"10.3389\/fphar.2021.759422","volume":"12","author":"JP Gil","year":"2021","unstructured":"Gil JP, Fan\u00e7ony C. Plasmodium falciparum multidrug resistance proteins (pfMRPs). Front Pharmacol. 2021;12:759422.","journal-title":"Front Pharmacol"},{"key":"6012_CR27","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.meegid.2012.12.014","volume":"14","author":"S Pirahmadi","year":"2013","unstructured":"Pirahmadi S, Zakeri S, Afsharpad M, Djadid ND. Mutation analysis in pfmdr1 and pfmrp1 as potential candidate genes for artemisinin resistance in Plasmodium falciparum clinical isolates 4 years after implementation of artemisinin combination therapy in Iran. Infect Genet Evol. 2013;14:327\u201334.","journal-title":"Infect Genet Evol"},{"key":"6012_CR28","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1128\/AAC.16.6.710","volume":"16","author":"RE Desjardins","year":"1979","unstructured":"Desjardins RE, Canfield CJ, Haynes JD, Chulay JD. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979;16:710\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"6012_CR29","volume-title":"World malaria report 2023","author":"WHO","year":"2023","unstructured":"WHO. World malaria report 2023. Geneva: World Health Organization; 2023."},{"key":"6012_CR30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1475-2875-6-148","volume":"6","author":"S Zakeri","year":"2007","unstructured":"Zakeri S, Afsharpad M, Raeisi A, Djadid ND. Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran. Malar J. 2007;6:148.","journal-title":"Malar J"},{"key":"6012_CR31","first-page":"189","volume":"72","author":"G Snounou","year":"2002","unstructured":"Snounou G, Singh B. Nested PCR analysis of Plasmodium parasites. Methods Mol Med. 2002;72:189\u2013203.","journal-title":"Methods Mol Med"},{"key":"6012_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0166-6851(00)00201-2","volume":"108","author":"MT Duraisingh","year":"2000","unstructured":"Duraisingh MT, Jones P, Sambou I, von Seidlein L, Pinder M, Warhurst DC. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the antimalarials mefloquine and artemisinin. Mol Biochem Parasitol. 2000;108:13\u201323.","journal-title":"Mol Biochem Parasitol"},{"key":"6012_CR33","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12936-020-03276-8","volume":"19","author":"AQ Khan","year":"2020","unstructured":"Khan AQ, Pernaute-Lau L, Khattak AA, Luijcx S, Aydin-Schmidt B, Hussain M, et al. Surveillance of genetic markers associated with Plasmodium falciparum resistance to artemisinin-based combination therapy in Pakistan, 2018\u20132019. Malar J. 2020;19:206.","journal-title":"Malar J"},{"key":"6012_CR34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.actatropica.2016.06.016","volume":"162","author":"LMQ Alareqi","year":"2016","unstructured":"Alareqi LMQ, Mahdy MAK, Lau YL, Fong MY, Abdul-Ghani R, Mahmud R. Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate, Yemen during the transmission season. Acta Trop. 2016;162:174\u20139.","journal-title":"Acta Trop"},{"key":"6012_CR35","doi-asserted-by":"publisher","first-page":"e2191","DOI":"10.7717\/peerj.2191","volume":"4","author":"WM Atroosh","year":"2016","unstructured":"Atroosh WM, Al-Mekhlafi HM, Al-Jasari A, Sady H, Dawaki SS, Elyana FN, et al. Different patterns of pfcrt and pfmdr1 polymorphism in Plasmodium falciparum isolates from Tehama region. Yemen PeerJ. 2016;4:e2191.","journal-title":"Yemen PeerJ"},{"key":"6012_CR36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.4269\/ajtmh.12-0695","volume":"89","author":"MR Adhin","year":"2013","unstructured":"Adhin MR, Labadie-Bracho M, Bretas G. Molecular surveillance as monitoring tool for drug-resistant Plasmodium falciparum in Suriname. Am J Trop Med Hyg. 2013;89:311\u20136.","journal-title":"Am J Trop Med Hyg"},{"key":"6012_CR37","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1128\/AAC.01243-09","volume":"54","author":"S Griffing","year":"2010","unstructured":"Griffing S, Syphard L, Sridaran S, McCollum AM, Mixson-Hayden T, Vinayak S, et al. pfmdr1 amplification and fixation of pfcrt chloroquine resistance alleles in Plasmodium falciparum in Venezuela. Antimicrob Agents Chemother. 2010;54:1572\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"6012_CR38","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1086\/422006","volume":"190","author":"PP Vieira","year":"2004","unstructured":"Vieira PP, Ferreira MU, Alecrim M, Alecrim WD, da Silva LH, Sihuincha MM, et al. pfcrt polymorphism and the spread of chloroquine resistance in Plasmodium falciparum populations across the Amazon Basin. J Infect Dis. 2004;190:417\u201324.","journal-title":"J Infect Dis"},{"key":"6012_CR39","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4269\/ajtmh.13-0647","volume":"91","author":"GW Mbogo","year":"2014","unstructured":"Mbogo GW, Nankoberanyi S, Tukwasibwe S, Baliraine FN, Nsobya SL, Conrad MD, et al. Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda. Am J Trop Med Hyg. 2014;91:54\u201361.","journal-title":"Am J Trop Med Hyg"},{"key":"6012_CR40","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/1475-2875-12-415","volume":"12","author":"A Mohammed","year":"2013","unstructured":"Mohammed A, Ndaro A, Kalinga A, Manjurano A, Mosha JF, Mosha DF, et al. Trends in chloroquine resistance marker, pfcrt K76T mutation ten years after chloroquine withdrawal in Tanzania. Malar J. 2013;12:415.","journal-title":"Malar J"},{"key":"6012_CR41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12936-023-04602-6","volume":"22","author":"G Tadele","year":"2023","unstructured":"Tadele G, Jawara A, Oboh M, Oriero E, Dugassa S, Amambua-Ngwa A, et al. Clinical isolates of uncomplicated falciparum malaria from high and low malaria transmission areas show distinct pfcrt and pfmdr1 polymorphisms in western Ethiopia. Malar J. 2023;22:171.","journal-title":"Malar J"},{"key":"6012_CR42","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41598-021-04450-x","volume":"12","author":"HM Al-Mekhlafi","year":"2022","unstructured":"Al-Mekhlafi HM, Madkhali AM, Abdulhaq AA, Atroosh WM, Ghzwani AH, Zain KA, et al. Polymorphism analysis of pfmdr1 gene in Plasmodium falciparum isolates 11 years post-adoption of artemisinin-based combination therapy in Saudi Arabia. Sci Rep. 2022;12:517.","journal-title":"Sci Rep"},{"key":"6012_CR43","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.17656.1","author":"I Omedo","year":"2022","unstructured":"Omedo I, Bartilol B, Kimani D, Gon\u00e7alves S, Drury E, Rono M, et al. Spatio-temporal distribution of antimalarial drug resistant gene mutations in a Plasmodium falciparum parasite population from Kilifi, Kenya: a 25-year retrospective study. Wellcome Open Res. 2022. https:\/\/doi.org\/10.12688\/wellcomeopenres.17656.1.","journal-title":"Wellcome Open Res"},{"key":"6012_CR44","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/1475-2875-12-377","volume":"12","author":"NO Duah","year":"2013","unstructured":"Duah NO, Matrevi SA, de Souza DK, Binnah DD, Tamakloe MM, Opoku VS, et al. Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of antimalarial drug treatment policy. Malar J. 2013;12:377.","journal-title":"Malar J"},{"key":"6012_CR45","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/infdis\/jir486","volume":"204","author":"FN Baliraine","year":"2011","unstructured":"Baliraine FN, Rosenthal PJ. Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda. J Infect Dis. 2011;204:1120\u20134.","journal-title":"J Infect Dis"},{"key":"6012_CR46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1475-2875-12-103","volume":"12","author":"M Malmberg","year":"2013","unstructured":"Malmberg M, Ngasala B, Ferreira PE, Larsson E, Jovel I, Hjalmarsson A, et al. Temporal trends of molecular markers associated with artemether-lumefantrine tolerance\/resistance in Bagamoyo district, Tanzania. Malar J. 2013;12:103.","journal-title":"Malar J"},{"key":"6012_CR47","doi-asserted-by":"publisher","first-page":"536","DOI":"10.4269\/ajtmh.12-0525","volume":"88","author":"TT Thomsen","year":"2013","unstructured":"Thomsen TT, Madsen LB, Hansson HH, Tom\u00e1s EV, Charlwood D, Bygbjerg IC, et al. Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane district, southern Mozambique. Am J Trop Med Hyg. 2013;88:536\u201341.","journal-title":"Am J Trop Med Hyg"},{"key":"6012_CR48","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/1475-2875-13-264","volume":"13","author":"RA Kavishe","year":"2014","unstructured":"Kavishe RA, Paulo P, Kaaya RD, Kalinga A, van Zwetselaar M, Chilongola J, et al. Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania. Malar J. 2014;13:264.","journal-title":"Malar J"},{"key":"6012_CR49","doi-asserted-by":"publisher","first-page":"979","DOI":"10.4269\/ajtmh.2011.11-0071","volume":"85","author":"TT Thomsen","year":"2011","unstructured":"Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, et al. Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (pfmdr1) in Korogwe district in Tanzania before and after introduction of artemisinin-based combination therapy. Am J Trop Med Hyg. 2011;85:979\u201383.","journal-title":"Am J Trop Med Hyg"},{"key":"6012_CR50","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/infdis\/jiv551","volume":"213","author":"A Yeka","year":"2016","unstructured":"Yeka A, Kigozi R, Conrad MD, Lugemwa M, Okui P, Katureebe C, et al. Artesunate\/amodiaquine versus artemether\/lumefantrine for the treatment of uncomplicated malaria in Uganda: a randomized trial. J Infect Dis. 2016;213:1134\u201342.","journal-title":"J Infect Dis"},{"key":"6012_CR51","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11686-025-01197-7","volume":"71","author":"S Mohammadi","year":"2025","unstructured":"Mohammadi S, Forouzesh F, Mehrizi AA, Shafi ZSM, Pakdel JD, Raeisi A, et al. Absence of artemisinin resistance-associated mutations in the Plasmodium falciparum kelch 13 (K13) propeller domain gene following widespread use of artemisinin-based combination therapy in Iran. Acta Parasitol. 2025;71:5.","journal-title":"Acta Parasitol"},{"key":"6012_CR52","doi-asserted-by":"publisher","first-page":"7687","DOI":"10.1074\/jbc.M806944200","volume":"284","author":"DK Raj","year":"2009","unstructured":"Raj DK, Mu J, Jiang H, Kabat J, Singh S, Sullivan M, et al. Disruption of a Plasmodium falciparum multidrug resistance-associated protein (pfMRP) alters its fitness and transport of antimalarial drugs and glutathione. J Biol Chem. 2009;284:7687\u201396.","journal-title":"J Biol Chem"},{"key":"6012_CR53","doi-asserted-by":"publisher","first-page":"e0298585","DOI":"10.1371\/journal.pone.0298585","volume":"19","author":"W Okore","year":"2024","unstructured":"Okore W, Ouma C, Okoth RO, Yeda R, Ingasia LO, Mwakio EW, et al. Increased sensitivity of malaria parasites to common antimalaria drugs after the introduction of artemether-lumefantrine: implication of policy change and implementation of more effective drugs in fight against malaria. PLoS ONE. 2024;19:e0298585.","journal-title":"PLoS ONE"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-026-06012-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-06012-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-06012-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:49:40Z","timestamp":1788324580000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12936-026-06012-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6012"],"URL":"https:\/\/doi.org\/10.1186\/s12936-026-06012-w","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Islamic Azad University, Tehran Medical Sciences Branch, Iran (IR.IAU.PS.REC.1402.549). Written consent was obtained from study participants or their guardians.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"317"}}